GET DAILY SIGNALSResolute Holdings Management (RHLD): Charting a Course Toward the $181 Target
Key Takeaways
- The central price objective used here is $181, roughly 10% above the latest verified price of about $164 (NYSE close on November 9, 2026).
- This figure is not a consensus; it reflects the most recent single-analyst objective cited in public coverage (a Buy with a $181 target), because Resolute Holdings has too little active analyst coverage for a meaningful average.
- Published analyst targets for Resolute Holdings Management, Inc. (RHLD) have ranged widely, from about $123 (Hold) to $229 (Buy), illustrating sharp disagreement as the stock has swung dramatically.
- Supportive factors include a recurring management-fee business model, the company's close tie to CompoSecure, and strong recent momentum (a more than 40% one-month rally).
- Principal risks include extreme volatility, a thin float, reported net losses, and heavy dependence on CompoSecure and a planned transaction with Husky.
- For deeper context, explore RHLD's Major News, Today's Price Move, Forecast, and Earnings pages.
- You can also explore Trending AI Robots to see how AI-driven trading tools are monitoring opportunities across the market.
Analyst Price Targets and the Limited Consensus View
Resolute Holdings Management, Inc. (RHLD) operates as a New York–based alternative asset management platform offering operating-management services such as capital allocation oversight and M&A execution to businesses including CompoSecure and GPGI. Incorporated only in 2024 with a small float, the company draws unusually thin sell-side coverage. MarketBeat lists a single active rating (Sell) with no consensus target, while TipRanks references a most recent single-analyst Buy objective at $181; earlier cited targets span roughly $123 (Hold) to $229 (Buy). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Absent a credible multi-analyst consensus, the $181 level serves here as a public-discussion reference point rather than an averaged target. The wide $123-to-$229 spread highlights a fast-evolving narrative more than a settled valuation, given the stock’s movement from below $100 to above $236 and back within its 52-week range.
Current Market Position and the Route to the Target
The latest verified price sits near $164, implying about 10% upside to reach $181 — a modest percentage move, even though the stock’s history shows it can cover that ground rapidly in either direction. RHLD’s 52-week range runs from approximately $96.79 to $236.19. After an early-2026 decline, the shares have climbed more than 40% over the past month. Attaining $181 would mark a partial retracement toward the January 2026 high rather than a fresh peak.
Factors That Could Support Progress Toward the Target
The recurring management-fee model forms the platform’s core strength. Management has emphasized fee-related earnings per share (EPS) — a non-GAAP metric that excludes non-controlling interests and one-time items — as a clearer indicator of underlying performance than reported net income, which has faced structural pressure. A recently expanded $30 million revolving credit facility and the completed reincorporation from Delaware to Nevada were presented as enhancements to financial flexibility and corporate structure. Ongoing momentum in alternative-asset management plus any positive developments in the CompoSecure and Husky relationship could further bolster sentiment.
Risks That Could Keep the Target Out of Reach
Substantial risks remain. As a micro-cap with a thin float and exceptionally high historical volatility, the stock is prone to sharp drawdowns. Reported earnings attributable to common stockholders have been negative, and the company stays heavily reliant on CompoSecure and the outcome of its planned Husky transaction — an arrangement that brings both opportunity and complexity. One analyst maintains a Sell rating, institutional ownership stays limited, and sentiment can shift quickly. Any weakening in the CompoSecure relationship, softer fee-related earnings, or a broader risk-off move in small-cap financials could hinder a push toward $181.
Technical Levels and Market Structure
For this name, durable levels outweigh short-term indicator readings. The January 2026 peak near $236 represents the primary long-term resistance, while the March 2026 low near $97 serves as the key support floor. In the nearer term, the recent trading band between roughly $147 and $165 merits attention; a decisive break above the upper end of that zone would place $181 within reach, whereas a move below the prior close near $153 could indicate fading momentum.
Time Horizon and Key Items to Monitor
Single-analyst price targets typically reflect a roughly 12-month research horizon, yet thin coverage leaves no firm consensus to anchor a timeline. Investors should track quarterly earnings and fee-related earnings disclosures, updates on the CompoSecure and Husky transaction, further credit-facility or balance-sheet announcements, and any new analyst initiations or rating changes. Small-cap sentiment and broader interest-rate expectations can also influence this high-beta name. I’m watching this closely for signs of sustained momentum.
Exploring AI Daily Buy/Sell Signals
In my view, Tickeron’s AI Daily Buy/Sell Signals provide a practical way to stay on top of fast-moving names like RHLD. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals drawn from shifting market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly covered stock, these signals can surface opportunities, track positions, and highlight trend changes more efficiently than manual methods alone. I find it helpful when reviewing setups like this one.
Final Assessment
Can RHLD reach $181? The level sits only about 10% above the latest price, so it remains within range — yet the path is not guaranteed. The stock benefits from a recurring-fee model and recent momentum, but it also carries exceptional volatility, reported net losses, and concentrated exposure to CompoSecure and the Husky transaction. With coverage limited to essentially one active voice and targets spanning $123 to $229, no reliable consensus exists to rely on. The $181 objective functions as one publicly discussed reference point rather than a forecast; investors should follow earnings, deal developments, and the technical zone near $165 for the next signals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RHLD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for RHLD turned positive on October 21, 2026. Looking at past instances where RHLD's MACD turned positive, the stock continued to rise in 13 of 14 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on RHLD as a result. In 20 of 27 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
RHLD moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RHLD crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +10.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where RHLD advanced for three days, in 76 of 94 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RHLD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
RHLD broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RHLD entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RHLD's P/B Ratio (-38.157) is slightly lower than the industry average of (5.887). P/E Ratio (26.919) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.904) is also within normal values, averaging (9.907).
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 9 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. RHLD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RHLD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry OfficeEquipmentSupplies
Advertisement